Skip to content
Top Globe News – Lifestyle
Author:
AMERICAN DIABETES ASSOCIATION
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
June 7, 2026
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
June 7, 2026
The American Diabetes Association Announces Winners of the Innovation Challenge
June 6, 2026
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
June 6, 2026
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
June 6, 2026
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
June 6, 2026
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
June 5, 2026
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
June 5, 2026
The American Diabetes Association’s Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease Management and Prevention
June 2, 2026
The American Diabetes Association Debuts the 2026 Scientific Sessions, Driving the Future of Diabetes Care
May 27, 2026
←
Previous Page
1
2